Anzahl der Einträge: 27.
Schnabel, M.J.,
Brummeisl, W.,
Burger, M.,
Rassweiler, J.J.,
Knoll, T.,
Neisius, A.,
Chaussy, C.G. und
Fritsche, H.M.
(2015)
Stoßwellenlithotripsie in Deutschland.
Der Urologe 54 (9), S. 1277-1282.
Volltext nicht vorhanden.
May, M.,
Brookman-May, S.,
Burger, M.,
Fritsche, H.M.,
Ebersdobler, A.,
Hakenberg, O.W. und
Gunia, S.
(2012)
514 P16INK4a is a marker of good prognosis in primary invasive penile squamous cell carcinoma: A multi-institutional study.
European Urology Supplements 11 (1), e514-e514a.
Volltext nicht vorhanden.
Brookman-May, S.,
Burger, M.,
May, M.,
Denzinger, S.,
Gierth, M.,
Siegert, S.,
Giedl, J.,
Agaimy, A.,
Wirth, M.P.,
Hofstädter, F.,
Wieland, W.F.,
Hartmann, A. und
Fritsche, H.M.
(2012)
558 Perinodal lymphovascular invasion displays the strongest predictor for cancer-specific mortality in lymph node positive patients with urothelial carcinoma of the bladder.
European Urology Supplements 11 (1), e558-e558a.
Volltext nicht vorhanden.
Rink, M.,
Ehdaie, B.,
Cha, E.K.,
Hansen, J.,
Svatek, R.,
Chromecki, T.F.,
Fajkovic, H.,
Novara, G.,
Daneshmand, S.,
Fradet, Y.,
Lotan, Y.,
Sagalowsky, A.I.,
Bastian, P.J.,
Kassouf, W.,
Fritsche, H.M.,
Burger, M.,
Izawa, J.,
Tilki, D.,
Abdollah, F.,
Chun, F.K.,
Sonpavde, G.,
Fisch, M.,
Scherr, D.,
Gonen, M. und
Shariat, S.F.
(2012)
603 Clinical nodal staging scores for bladder cancer: A proposal for preoperative risk-assessment.
European Urology Supplements 11 (1), e603-e603b.
Volltext nicht vorhanden.
Otto, W.,
May, M.,
Fritsche, H.M.,
Bolenz, C.,
Trojan, L.,
Herrmann, E.,
Tiemann, A.,
Müller, S.C.,
Ellinger, J.,
Buchner, A.,
Stief, C.G.,
Tilki, D.,
Brookman-May, S.,
Denzinger, S.,
Wieland, W.F.,
Höfner, T.,
Hohenfellner, M.,
Haferkamp, A.,
Roigas, J.,
Zacharias, M.,
Bastian, P.J. und
Burger, M.
(2012)
775 Female gender is associated with worse cancer-specific survival after radical cystectomy for urothelial bladder carcinoma: Multicenter analysis of 2,483 patients.
European Urology Supplements 11 (1), e775-e775a.
Volltext nicht vorhanden.
Bründl, J.,
Fritsche, H.M.,
Gierth, M.,
Brandtner, A.,
Wieland, W.F. und
Ganzer, R.
(2012)
798 Combination of real-time elastography targeted and randomized biopsy of the prostate in a prospective patient series.
European Urology Supplements 11 (1), e798-e798a.
Volltext nicht vorhanden.
Fritsche, H.M.,
May, M.,
Burger, M.,
Nuhn, P.,
Otto, W.,
Buchner, A.,
Bolenz, C.,
Herrmann, E.,
Ellinger, J.,
Höfner, T.,
Tilki, D.,
Roigas, J.,
Zacharias, M.,
Trojan, L.,
Haferkamp, A.,
Gilfrich, C.,
Hertle, L.,
Hohenfellner, M.,
Müller, S.C.,
Stief, C.G.,
Wieland, W.F. und
Bastian, P.J.
(2012)
872 External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder.
European Urology Supplements 11 (1), e872-e872a.
Volltext nicht vorhanden.
Ganzer, R.,
Fritsche, H.M.,
Brandtner, A.,
Bründl, J.,
Koch, D. und
Wieland, W.F.
(2012)
981 Survival analysis of patients following prostate cancer treatment with high intensity focused ultrasound (HIFU) during a treatment period of 13 years.
European Urology Supplements 11 (1), e981-e981a.
Volltext nicht vorhanden.
Buchner, A.,
May, M.,
Bolenz, C.,
Herrmann, E.,
Höfner, T.,
Fritsche, H.M.,
Wülfing, C.,
Burger, M.,
Trojan, L.,
Tilki, D.,
Haferkamp, A.,
Michel, M.S.,
Ellinger, J.,
Gilfrich, C. ,
Roigas, J.,
Hertle, L.,
Hohenfellner, M.,
Wieland, W.F.,
Müller, S.C. und
Bastian, P.J.
(2011)
243 PREDICTION OF LOCALLY ADVANCED BLADDER CANCER BEFORE CYSTECTOMY AND OUTCOME ASSESSMENT OF PATIENTS WITH BLADDER CANCER AFTER CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS.
European Urology Supplements 10 (2), S. 98.
Volltext nicht vorhanden.
Bastian, P.J.,
May, M.,
Sun, M.,
Buchner, A.,
Fritsche, H.M.,
Nuhn, P.,
Bolenz, C.,
Brookman-May, S.,
Otto, W.,
Herrmann, E.,
Trojan, L.,
Rud, O.,
Peter, J.,
Michel, M.S.,
Wülfing, C.,
Perotte, P.,
Tiemann, A.,
Ellinger, J.,
Müller, S.C.,
Tilki, D.,
Wieland, W.F.,
Gilfrich, C. ,
Höfner, T.,
Hohenfellner, M.,
Haferkamp, A.,
Roigas, J.,
Bretschneiderehrenberg, P.,
Müller, O.,
Zacharias, M.,
Gunia, S.,
Karakiewicz, P.I. und
Burger, M.
(2011)
244 MULTICENTRIC VALIDATION OF NOMOGRAMS TO PREDICT LOCALLY ADVANCED UROTHELIAL CANCER OF THE BLADDER AND SURVIVAL RATES FOLLOWING RADICAL CYSTECTOMY.
European Urology Supplements 10 (2), S. 98.
Volltext nicht vorhanden.
Mavr, R.,
Martini, T.,
Pycha, A.,
Lodde, M.,
Comploj, E.,
Denzinger, S.,
Otto, W.,
Burger, M. und
Fritsche, H.M.
(2011)
45 PREDICTIVE CAPACITY OF FOUR COMORBIDITY INDICES ESTIMATING MORTALITY AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER.
European Urology Supplements 10 (2), S. 42.
Volltext nicht vorhanden.
Fritsche, H.M.,
Otto, W.,
Eder, F.,
Hofstädter, F.,
Denzinger, S.,
Burger, M. und
Wieland, W.F.
(2011)
538 WATERJET AIDED TRANSURETHRAL DISSECTION OF UROTHELIAL CARCINOMA: A PROSPECTIVE CLINICAL STUDY.
European Urology Supplements 10 (2), S. 179.
Volltext nicht vorhanden.
Bastian, P.J.,
May, M.,
Hermann, E.,
Buchner, A.,
Bolenz, C.,
Fritsche, H.M.,
Brookman-May, S.,
Tiemann, A.,
Burger, M.,
Gratzke, C.,
Trojan, L.,
Michel, M.S.,
Wülfing, C.,
Müller, S.C.,
Ellinger, J.,
Wieland, W.F.,
Tilki, D.,
Gilfrich, C. ,
Höfner, T.,
Hophenfellner, M.,
Roigas, J.,
Zacharias, M.,
Gunia, S. und
Haferkamp, A.
(2011)
866 ASSOCIATION BETWEEN THE EXTENT OF PELVIC LYMPHADENECTOMY AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER UNDERGOING RADICAL CYSTECTOMY.
European Urology Supplements 10 (2), S. 273.
Volltext nicht vorhanden.
Novara, G.,
Walton, T.,
Gupta, A.,
Matsumoto, K.,
Bastian, P.,
Kassouf, W.,
Fritsche, H.M.,
Martínez-Salamanca, J.I.,
Seitz, C.,
Ficarra, V.,
Karakiewicz, P.I. und
Shariat, S.F.
(2010)
1027 ONCOLOGICAL OUTCOMES FOR OPEN AND LAPAROSCOPIC NEPHROURETERECTOMY: A MULTI-INSTITUTIONAL EXTERNAL VALIDATION STUDY FROM THE UPPER TRACT UROTHELIAL CARCINOMA COLLABORATION.
European Urology Supplements 9 (2), S. 321-322.
Volltext nicht vorhanden.
Tilki, D.,
Reich, O.,
Svatek, R.S.,
Karakiewicz, P.I.,
Kassouf, W.,
Novara, G.,
Ficarra, V.,
Chade, D.C.,
Fritsche, H.M.,
Gerwens, N.,
Izawa, J.I.,
Lerner, S.P.,
Schoenberg, M.,
Skinner, E.,
Lotan, Y.,
Sagalowsky, A.I.,
Stief, C.G. und
Shariat, S.F.
(2010)
199 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CLINICAL CARCINOMA IN SITU ONLY TREATED WITH RADICAL CYSTECTOMY: AN INTERNATIONAL STUDY OF 243 PATIENTS.
European Urology Supplements 9 (2), S. 94.
Volltext nicht vorhanden.
Reich, O.,
Tilki, D.,
Svatek, R.S.,
Karakiewicz, P.I.,
Isbarn, H.,
Kassouf, W.,
Fradet, Y.,
Novara, G.,
Fritsche, H.M.,
Bastian, P.J.,
Izawa, J.I.,
Ficarra, V.,
Lerner, S.P.,
Schoenberg, M.,
Dinney, P.,
Skinner, E.,
Lotan, Y.,
Sagalowsky, A.I.,
Stief, C.G. und
Shariat, S.F.
(2010)
322 CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH PT4 UROTHELIAL CARCINOMA AT RADICAL CYSTECTOMY: A RETROSPECTIVE INTERNATIONAL STUDY OF 583 PATIENTS.
European Urology Supplements 9 (2), S. 127.
Volltext nicht vorhanden.
Shariat, S.F.,
Svatek, R.,
Tilki, D.,
Skinner, E.,
Karakiewicz, P.I.,
Capitanio, U.,
Bastian, P.I.,
Volkmer, B.G.,
Kassouf, W.,
Novara, G.,
Fritsche, H.M.,
Izawa, J.I.,
Ficarra, V.,
Lerner, S.P.,
Sagalowsky, A.I.,
Lotan, Y.,
Schoenberg, M.P.,
Kamat, A.M.,
Dinney, C.P.,
Marberger, M.J. und
Fradet, Y.
(2010)
323 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN RADICAL CYSTECTOMY PATIENTS.
European Urology Supplements 9 (2), S. 127.
Volltext nicht vorhanden.
Burger, M.,
Denzinger, S.,
Hartmann, A.,
Wieland, W.F.,
Otto, W. und
Fritsche, H.M.
(2010)
326 INCIDENTAL AND CLINICALLY RELEVANT PROSTATE CANCER IS FOUND MORE FREQUENTLY IN THOROUGH VERSUS STANDARD HISTOPATHOLOGICAL PROCESSING IN RADICAL CYSTOPROSTATECTOMY SPECIMEN AND SHOULD BE CONSIDERED IN YOUNGER MEN.
European Urology Supplements 9 (2), S. 128.
Volltext nicht vorhanden.
Nuhn, P.,
Bastian, P.J.,
Svatek, R.S.,
Karakiewicz, P.I.,
Skinner, E.,
Fradet, Y.,
Izawa, J.I.,
Kassouf, W.,
Novara, G.,
Montorsi, F.,
Fritsche, H.M.,
Tilki, D.,
Isbarn, H.,
Ficarra, V.,
Dinney, C.P. und
Shariat, S.F.
(2010)
35 CONCOMITANT CARCINOMA IN SITU IS NOT ASSOCIATED WITH CLINICAL OUTCOMES AFTER RADICAL CYSTECTOMY.
European Urology Supplements 9 (2), S. 45.
Volltext nicht vorhanden.
Fritsche, H.M.,
Novara, G.,
Gupta, A.,
Matsumoto, K.,
Kassouf, W.,
Walton, T.,
Burger, M.,
Tritschler, S.,
Baba, S.,
Bastian, P.J.,
Carballido, J. ,
Seitz, C.,
Otto, W.,
Karakiewicz, P.I.,
Ficarra, V. und
Shariat, S.F.
(2010)
37 VALIDATION OF TUMOUR ARCHITECTURE IS AN INDEPENDENT PREDICTOR OF OUTCOMES AFTER RADICAL NEPHROURETERECTOMY.
European Urology Supplements 9 (2), S. 45.
Volltext nicht vorhanden.
Otto, W.,
Fritsche, H.M.,
Bertz, S.,
Burger, M.,
Rößler, W.,
Wieland, W.F.,
Hartmann, A. und
Denzinger, S.
(2010)
43 VALUE OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS FOR PROGNOSIS OF PT1 UROTHELIAL BLADDER CANCER: A SINGLE-CENTER ANALYSIS OF 309 PATIENTS.
European Urology Supplements 9 (2), S. 47.
Volltext nicht vorhanden.
Keck, B.,
Stoehr, R.,
Wach, S.,
Rogler, A.,
Fritsche, H.M.,
Lehmann, J.,
Wullich, B. und
Hartmann, A.
(2010)
923 PLASMACYTOID UROTHELIAL CARCINOMA: RARE VARIANT OF AGGRESSIVE UROTHELIAL CARCINOMA.
European Urology Supplements 9 (2), S. 290.
Volltext nicht vorhanden.
Fritsche, H.M.,
Burger, M.,
Otto, W.,
Buchner, H.,
Ganzer, R.,
Denzinger, S.,
Bastian, P. und
Wieland, W.F.
(2008)
A CONTRIBUTION TO THE USE OF NOMOGRAMS AS PREDICTIVE TOOLS FOR BLADDER CANCER: THERE'S STILL A LONG WAY TO GO.
European Urology Supplements 7 (3), S. 319.
Volltext nicht vorhanden.
Keck, B. ,
Stöhr, R.,
Goebell, P.J.,
Fritsche, H.M.,
Wullich, B. und
Hartmann, A.
(2008)
Das plasmazytoide Urothelkarzinom.
Der Pathologe 29 (5), S. 379-382.
Volltext nicht vorhanden.
Fritsche, H.M.,
Burger, M.,
Denzinger, S.,
Legal, W.,
Goebell, P.J. und
Hartmann, A.
(2008)
Plasmacytoid Urothelial Carcinoma of the Bladder: Histological and Clinical Features of 5 Cases.
Journal of Urology 180 (5), S. 1923-1927.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Sat Dec 21 19:12:56 2024 CET.